Cargando…

Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage

BACKGROUND: The RTS,S/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study seeks to identify whether vaccination could reach additional children who are at risk from malaria but do not currently have access to...

Descripción completa

Detalles Bibliográficos
Autores principales: Unwin, H. Juliette T., Mwandigha, Lazaro, Winskill, Peter, Ghani, Azra C., Hogan, Alexandra B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597213/
https://www.ncbi.nlm.nih.gov/pubmed/34789253
http://dx.doi.org/10.1186/s12936-021-03966-x
_version_ 1784600564528578560
author Unwin, H. Juliette T.
Mwandigha, Lazaro
Winskill, Peter
Ghani, Azra C.
Hogan, Alexandra B.
author_facet Unwin, H. Juliette T.
Mwandigha, Lazaro
Winskill, Peter
Ghani, Azra C.
Hogan, Alexandra B.
author_sort Unwin, H. Juliette T.
collection PubMed
description BACKGROUND: The RTS,S/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study seeks to identify whether vaccination could reach additional children who are at risk from malaria but do not currently have access to, or use, core malaria interventions. METHODS: Using data from household surveys, the overlap between malaria intervention coverage and childhood vaccination (diphtheria-tetanus-pertussis dose 3, DTP3) uptake in 20 African countries with at least one first administrative level unit with Plasmodium falciparum parasite prevalence greater than 10% was calculated. Multilevel logistic regression was used to explore patterns of overlap by demographic and socioeconomic variables. The public health impact of delivering RTS,S/AS01 to those children who do not use an insecticide-treated net (ITN), but who received the DTP3 vaccine, was also estimated. RESULTS: Uptake of DTP3 was higher than malaria intervention coverage in most countries. Overall, 34% of children did not use ITNs and received DTP3, while 35% of children used ITNs and received DTP3, although this breakdown varied by country. It was estimated that there are 33 million children in these 20 countries who do not use an ITN. Of these, 23 million (70%) received the DTP3 vaccine. Vaccinating those 23 million children who receive DTP3 but do not use an ITN could avert up to an estimated 9.7 million (range 8.5–10.8 million) clinical malaria cases each year, assuming all children who receive DTP3 are administered all four RTS,S doses. An additional 10.8 million (9.5–12.0 million) cases could be averted by vaccinating those 24 million children who receive the DTP3 vaccine and use an ITN. Children who had access to or used an ITN were 9–13% more likely to reside in rural areas compared to those who had neither intervention regardless of vaccination status. Mothers’ education status was a strong predictor of intervention uptake and was positively associated with use of ITNs and vaccination uptake and negatively associated with having access to an ITN but not using it. Wealth was also a strong predictor of intervention coverage. CONCLUSIONS: Childhood vaccination to prevent malaria has the potential to reduce inequity in access to existing malaria interventions and could substantially reduce the childhood malaria burden in sub-Saharan Africa, even in regions with lower existing DTP3 coverage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-03966-x.
format Online
Article
Text
id pubmed-8597213
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85972132021-11-17 Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage Unwin, H. Juliette T. Mwandigha, Lazaro Winskill, Peter Ghani, Azra C. Hogan, Alexandra B. Malar J Research BACKGROUND: The RTS,S/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study seeks to identify whether vaccination could reach additional children who are at risk from malaria but do not currently have access to, or use, core malaria interventions. METHODS: Using data from household surveys, the overlap between malaria intervention coverage and childhood vaccination (diphtheria-tetanus-pertussis dose 3, DTP3) uptake in 20 African countries with at least one first administrative level unit with Plasmodium falciparum parasite prevalence greater than 10% was calculated. Multilevel logistic regression was used to explore patterns of overlap by demographic and socioeconomic variables. The public health impact of delivering RTS,S/AS01 to those children who do not use an insecticide-treated net (ITN), but who received the DTP3 vaccine, was also estimated. RESULTS: Uptake of DTP3 was higher than malaria intervention coverage in most countries. Overall, 34% of children did not use ITNs and received DTP3, while 35% of children used ITNs and received DTP3, although this breakdown varied by country. It was estimated that there are 33 million children in these 20 countries who do not use an ITN. Of these, 23 million (70%) received the DTP3 vaccine. Vaccinating those 23 million children who receive DTP3 but do not use an ITN could avert up to an estimated 9.7 million (range 8.5–10.8 million) clinical malaria cases each year, assuming all children who receive DTP3 are administered all four RTS,S doses. An additional 10.8 million (9.5–12.0 million) cases could be averted by vaccinating those 24 million children who receive the DTP3 vaccine and use an ITN. Children who had access to or used an ITN were 9–13% more likely to reside in rural areas compared to those who had neither intervention regardless of vaccination status. Mothers’ education status was a strong predictor of intervention uptake and was positively associated with use of ITNs and vaccination uptake and negatively associated with having access to an ITN but not using it. Wealth was also a strong predictor of intervention coverage. CONCLUSIONS: Childhood vaccination to prevent malaria has the potential to reduce inequity in access to existing malaria interventions and could substantially reduce the childhood malaria burden in sub-Saharan Africa, even in regions with lower existing DTP3 coverage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-03966-x. BioMed Central 2021-11-17 /pmc/articles/PMC8597213/ /pubmed/34789253 http://dx.doi.org/10.1186/s12936-021-03966-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Unwin, H. Juliette T.
Mwandigha, Lazaro
Winskill, Peter
Ghani, Azra C.
Hogan, Alexandra B.
Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
title Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
title_full Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
title_fullStr Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
title_full_unstemmed Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
title_short Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
title_sort analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597213/
https://www.ncbi.nlm.nih.gov/pubmed/34789253
http://dx.doi.org/10.1186/s12936-021-03966-x
work_keys_str_mv AT unwinhjuliettet analysisofthepotentialforamalariavaccinetoreducegapsinmalariainterventioncoverage
AT mwandighalazaro analysisofthepotentialforamalariavaccinetoreducegapsinmalariainterventioncoverage
AT winskillpeter analysisofthepotentialforamalariavaccinetoreducegapsinmalariainterventioncoverage
AT ghaniazrac analysisofthepotentialforamalariavaccinetoreducegapsinmalariainterventioncoverage
AT hoganalexandrab analysisofthepotentialforamalariavaccinetoreducegapsinmalariainterventioncoverage